retatrutide phase 2 nejm weight loss 48 weeks percent (not yet approved in US but people using anyway) promises even potentially greater amongst the GLP1 drugs. https://www.nejm .org/doi/full/10.1056/NEJMoa2301972 Early trial data for retatrutide
Description
The comments are open
Knudsen LB, et al
Effect of incretin-based therapies on blood pressure: a systematic review and meta-analysis
A doctor can also provide guidance on nutrition and activity, which are crucial to success with GLP-1 medications. What Risks Can You Avoid By Working With A Doctor
Practical Tips and Next Steps Turning the science into daily habits is where most people need clear, simple ideas
The volume of each weekly dose depends on the experimental protocol and concentration of the reconstituted solution
